AKT1 and inflammatory bowel disease: In the context of resident gut bacteria, pathobionts such as Fusobacterium nucleatum which are implicated in disease development in IBD, esophageal cancer, and colorectal cancer [38,39], have also been found to activate PI3K/Akt pathway [40,41].